• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5905.0
  • ISIN : INE646B01010
315.30 9 (2.87%)
  • As on 27 Sep 2026 (EOD)

  • Today’s Low

    292.40

  • Today’s High

    319.80

  • Open

    307.95

  • Perv Close

    306.50

  • 52W Low

    212.40

  • 52W High

    447.65

Key Indicators

  • P/E(TTM)

    42.04

  • Mar.Cap (₹Cr.)

    427.64

  • Div & Yield %

    0.31

  • Book Value(₹)

    199.90

  • Debt-Equity Ratio

    2.87

  • AGM Date

    25-Sep-2026

  • EPS

    7.59

  • P/E Ratio

    42.04

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    427.64

  • RONW (%)

    4.74

  • ROCE (%)

    8.14

Score Board

  • Equity (₹ in Cr.)

    13.56

  • BV (₹)

    199.90

  • Sales( ₹ in Cr.)

    178.85

  • NP (in Cr.)

    9.41

  • NP Var(%)

    0.0

  • Div%

    10.0

  • CPS (₹)

    12.10

  • EPS (₹)

    6.90

  • Traded Value (₹ in Lakhs)

    432.72

  • 52 Week High

    447.65

  • 52 Week Low

    212.40

  • Price BSE

    319.0

  • Price NSE

    315.00

  • Market Capital( in Cr.)

    432.72

  • P/C Ratio

    26.30

  • P/E Ratio

    46.00

  • Price Vs.BV

    6.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 178.85 151.46 172.39 137.88 115.45 110.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 178.85 151.46 172.39 137.88 115.45 110.15
Other Income 3.10 6.23 2.30 2.46 1.72 0.75
Stock Adjustments -7.42 6.08 13.32 10.30 3.34 -1.04
Total Income 174.53 163.77 188.01 150.64 120.51 109.86
EXPENDITURE :            
Raw Materials 91.81 88.83 104.70 81.80 55.69 65.84
Power and Fuel Cost 8.05 6.94 7.12 5.67 5.86 2.68
Employee Cost 22.79 21.57 22.12 18.57 14.50 8.79
Other Manufacturing Expenses 14.23 10.87 10.24 8.70 9.60 7.37
Selling and Administration Expenses 13.91 11.01 12.42 6.65 7.50 3.94
Miscellaneous Expenses 1.20 1.21 1.87 2.18 1.52 0.46
Employee Benefit Expenses 22.79 21.57 22.12 18.57 14.50 8.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 151.98 140.43 158.47 123.56 94.69 89.08
Operating Profit 22.54 23.34 29.55 27.08 25.82 20.78
Interest 3.93 3.60 5.65 3.39 1.94 1.51
Gross Profit 18.61 19.74 23.90 23.69 23.88 19.27
Depreciation 7.06 6.96 7.01 6.35 5.77 2.52
Profit Before Tax 11.55 12.78 16.89 17.34 18.11 16.75
Current Tax 2.55 3.64 4.22 3.70 3.98 4.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.41 -0.31 -0.63 -1.37 -0.78 0.12
Reported Net Profit 9.41 9.45 13.30 15.00 14.91 12.49
Extraordinary Items 0.00 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 9.41 9.45 13.30 15.01 14.91 12.49
Adjustment below Net Profit 0.47 0.26 0.00 0.09 0.00 0.00
P & L Balance brought forward 102.61 94.18 82.15 68.32 54.43 42.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.36 1.27 1.27 1.27 1.22 0.61
P & L Balance carried down 111.13 102.61 94.18 82.15 68.12 54.43
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 1.00 1.00
Earnings Per Share-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Earnings Per Share(Adj)-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Book Value 199.90 171.17 164.54 152.30 121.18 109.98
Book Value(Adj)-Unit Curr 199.90 171.17 164.54 152.30 121.18 109.98

Shareholding Pattern

  • Promoter Group

    40.46%

  • Public Share Holding

    59.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,487,095 40.46 5,487,095 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,487,095 40.46 5,487,095 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.05 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,610 0.07 9,610 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 54,686 0.40 54,686 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 71,296 0.53 71,296 4
2] Non Institution
Bodies Corporate 297,388 2.19 295,888 93
Clearing Members 33,633 0.25 33,633 6
Directors of their Relatives 103,007 0.76 103,007 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 363,717 2.68 363,717 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 128,491 0.95 128,291 171
Foreign Non Institution Other 1,939,995 14.30 1,939,995 2
Hindu Undivided Families 385,089 2.84 385,089 354
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,033,586 7.62 1,033,586 19
Individuals holding nominal share capital up to Rs. 1 lakh 3,320,635 24.48 3,280,415 10,382
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 329,861 2.43 329,861 3
Sub Total 8,004,424 59.02 7,962,504 11,042
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,562,815 100.00 13,520,895 11,047

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

  • Medicamen Biotech Ltd
  • BSE Code : 5905.0
  • ISIN : INE646B01010

  • Incorporation Year

    1993

  • Registered Office

    1506 Chiranjiv Tower 43
    Nehru Place, New Delhi,
    New Delhi-110019

  • Telephone

    91-11-47589500

  • FAX

    91-11-26213081

  • Chairman

    Rahul Bishnoi

  • Managing Director

  • Company Secretary

    Parul Choudhary

  • Auditor

    Rai Qimat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Medicamen Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Biotec 319.05 181.95 178.85 42.04 5.46
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77